Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
AXSM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading AXSM News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
3.09%16.6810.2%$225.31m
SHPGShire PLC Sponsored ADR
0.88%182.880.3%$189.99m
PRGOPerrigo Co. Plc
0.27%84.664.3%$136.99m
MNKMallinckrodt Plc
2.27%54.5911.1%$114.80m
MDCOMedicines Company
2.23%53.2219.0%$112.73m
ENDPEndo International Plc
1.07%13.299.0%$92.81m
UTHRUnited Therapeutics Corporation
3.95%152.5112.7%$87.16m
PRXLPAREXEL International Corporation
0.49%66.267.5%$86.69m
ICPTIntercept Pharmaceuticals, Inc.
4.77%124.8721.9%$77.68m
JAZZJazz Pharmaceuticals Plc
0.63%136.972.3%$66.57m
SAGESAGE Therapeutics, Inc.
10.45%68.8112.1%$53.28m
PTLAPortola Pharmaceuticals, Inc.
4.45%34.998.8%$48.67m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.35%125.4110.9%$48.64m
SGYPSynergy Pharmaceuticals, Inc.
7.83%5.9216.1%$42.20m
HZNPHorizon Pharma plc
-5.56%16.4811.1%$41.77m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.